Johns Hopkins University
Clinical trials sponsored by Johns Hopkins University, explained in plain language.
-
Antioxidant pill may preserve sight in inherited eye disease
Disease control OngoingThis phase 3 trial tests whether an oral antioxidant called N-acetylcysteine (NAC) can slow the loss of vision in people with retinitis pigmentosa, an inherited eye disease that causes night blindness and tunnel vision. About 485 adults aged 18 to 65 will take NAC or a placebo da…
Phase: PHASE3 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Apr 29, 2026 02:39 UTC
-
Experimental womb fluid therapy aims to save babies with fatal kidney condition
Disease control OngoingThis study tests an experimental treatment for pregnant women whose babies have no amniotic fluid because of severe kidney problems. The treatment involves repeatedly adding sterile fluid into the womb to help the baby's lungs grow enough to survive after birth. The study include…
Phase: PHASE1 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Apr 29, 2026 02:38 UTC
-
Could a nose transplant from mom or dad shield babies from dangerous staph?
Disease control OngoingThis early study tests whether giving a newborn a small dose of their parent's healthy nasal bacteria can help prevent staph infections. The trial involves 34 infants in the NICU and their parents. Researchers will check if the baby's nose bacteria become more diverse and resista…
Phase: PHASE1 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Apr 29, 2026 02:38 UTC
-
Magic mushroom compound targets depression and drinking together
Symptom relief OngoingThis study looks at whether psilocybin, the active ingredient in magic mushrooms, can help people who have both major depression and alcohol use disorder. About 90 adults will receive psilocybin in a controlled setting to see if it reduces depressive symptoms and heavy drinking. …
Phase: PHASE2 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Apr 29, 2026 02:39 UTC
-
Can ketamine beat MS fatigue? new trial investigates
Symptom relief OngoingThis study tests whether low-dose ketamine infusions can reduce fatigue in people with multiple sclerosis (MS). About 110 adults with MS and significant fatigue will receive either ketamine or a placebo. The goal is to see if ketamine can safely improve fatigue symptoms.
Phase: PHASE2 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Apr 29, 2026 02:38 UTC
-
New shot could loosen stiff muscles after stroke
Symptom relief OngoingThis study tests if an injection of hyaluronidase can help reduce muscle stiffness in the arm after a stroke. About 56 people with moderate to severe arm stiffness will receive either the study drug or a placebo, and later switch to the other option. The goal is to see if the tre…
Phase: PHASE2 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Apr 29, 2026 02:37 UTC
-
New Needle-Guiding ultrasound device study pulled before starting
Knowledge-focused TerminatedThis study was designed to see if a new ultrasound device with a needle guide could help doctors place needles into the femoral artery more safely during a liver cancer treatment called chemoembolization. The study was withdrawn before any participants were enrolled, so no result…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Apr 29, 2026 02:39 UTC
-
Food dye could turn skin transparent, but study never started
Knowledge-focused TerminatedThis study was designed to test if tartrazine, a common yellow food dye, could be rubbed on the skin to make it temporarily transparent. Researchers planned to apply different doses to healthy volunteers and take pictures to see if they could better see blood vessels and other st…
Phase: EARLY_PHASE1 • Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Apr 29, 2026 02:37 UTC
-
Could hidden antibodies be behind mysterious gut issues?
Knowledge-focused OngoingThis study aims to find new antibodies in the blood that might be causing certain stomach and bowel movement disorders. Researchers will analyze blood samples from 300 people over age 13 who have ongoing gut symptoms. The goal is to better understand if the immune system is attac…
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Apr 29, 2026 02:37 UTC